Learn more about our policy experts.

Media Contacts

Angela Bradbery, Director of Communications
w. (202) 588-7741
c. (202) 503-6768
abradbery@citizen.org, Twitter

Don Owens, Deputy Director of Communications
w. (202) 588-7767

Karilyn Gower, Press Officer
w. (202) 588-7779

David Rosen, Press Officer, Regulatory Affairs
w. (202) 588-7742

Nicholas Florko, Communications Officer, Global Trade Watch
w. (202) 454-5108

Other Important Links

Press Release Database
Citizen Vox blog
Texas Vox blog
Consumer Law and Policy blog
Energy Vox blog
Eyes on Trade blog

Follow us on Twitter


Oct. 11, 2012

Indonesian Government Takes Bold Stance to Reduce Costs of AIDS Medications, Potentially Saving Thousands of Lives

Statement of Peter Maybarduk, Director, Public Citizen’s Global Access to Medicines Program

With a single decree, Indonesian President Dr. H. Susilo Bambang Yudhoyono has taken a quiet but exceptionally important step to expand access to medicines, potentially saving and improving the lives of tens of thousands of people living with HIV/AIDS and hepatitis B. If fully implemented, the measure will introduce widespread competition from generic versions of pricey brand-name drugs and generate major cost savings in the world’s fourth-most populous country.

Indonesia’s action sets a powerful example for other countries and a critical precedent for global public health. The decree licenses patents for a slate of HIV medicines and represents one of the most robust uses of pharmaceutical patent licensing power ever used by a country.

By taking such a bold stance, President Yudhoyono and all of Indonesia can take great pride in standing up for the right of those suffering from HIV/AIDS and hepatitits B to get the medicine they need. This action is part of an effort to greatly expand access to newer and more useful antiviral and antiretroviral treatments in Indonesia.

Public Citizen has provided technical assistance to patient advocates in Indonesia on this issue. We congratulate the work of Sindi Putri and Abdullah Denovan, as well as their colleagues at International Treatment Preparedness Coalition Indonesia and JOTHI, among other organizations, who are helping advance access to these important medications in Indonesia.

For more information, including a copy of the decree (in Indonesian and a rough unofficial English translation), analysis, a table of the licensed medicines and more on Indonesia’s response to HIV and hepatitis B, visit www.citizen.org/actions-indonesia.

To read more about the global campaign to improve access to second-line HIV/AIDS treatment, visit www.citizen.org/Kaletra-campaign.

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.


To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.